首页> 外国专利> Method for the reduction of viral loads in patients comprising the administration of nef-deficient human immunodeficiency virus (HIV)

Method for the reduction of viral loads in patients comprising the administration of nef-deficient human immunodeficiency virus (HIV)

机译：减少患者病毒载量的方法，包括施用 nef 缺陷型人类免疫缺陷病毒（HIV）

展开▼

新浪微博

QQ群

QQ空间

页面导航

摘要

著录项

相似文献

摘要

A therapeutic suspension for the treatment of human immunodeficiency virus type I (HIV-1) infection in humans using isolated and purified HIV-1 nef-deficient viral particles having a nef-deletion between the endonuclease cleavage sites Nco I and Xho I. 展开▼

机译：一种治疗性悬浮液，用于治疗分离的纯化的HIV-1缺乏Nef核酸内切酶位点Nco I和Xho I之间的HIV-1缺乏Nef的病毒颗粒，从而治疗人的人类I型免疫缺陷病毒（HIV-1）感染。展开▼

著录项

公开/公告号US8124102B2

专利类型

公开/公告日2012-02-28

原文格式PDF

申请/专利权人 SATEESH APTE;
展开▼

申请/专利号US20090321456

发明设计人 SATEESH APTE;
展开▼

申请日2009-01-21

分类号A61K39/21;

国家 US

入库时间 2022-08-21 17:26:51

相似文献

专利

外文文献

中文文献

1. 一种测定人类免疫缺陷病毒（1＋2型）不同抗原表位产生的特异性HIV抗体的方法及抗原条 [P] . 中国专利： CN101082625B . 2012.06.27

2. 一种测定人类免疫缺陷病毒（1＋2型）不同抗原表位产生的特异性HIV抗体的方法及抗原条 [P] . 中国专利： CN101082625A . 2007-12-05

3. Methods of generating a humoral immune response against human immunodeficiency virus (HIV) comprising administering Nef apoptotic motif-containing polypeptide-conjugates [P] . 美国专利： US7943139B2 . 2011-05-17

机译：产生针对人免疫缺陷病毒（HIV）的体液免疫应答的方法，包括施用含有Nef凋亡基序的多肽-缀合物

4. Human immunodeficiency virus vaccine and replication method comprising replication-impaired HIV-1 nef deletion mutant [P] . 日本专利： JP4587496B2 . 2010-11-24

机译：包含复制受损的HIV-1 nef缺失突变体的人免疫缺陷病毒疫苗和复制方法

5. Immunogenic compositions comprising human immunodeficiency virus (HIV) mosaic Nef proteins [P] . 美国专利： US8119140B2 . 2012-02-21

机译：包含人免疫缺陷病毒（HIV）镶嵌Nef蛋白的免疫原性组合物

1. Disseminated cutaneous leishmaniasis due to Leishmania (Leishmania) amazonensis in human immunodeficiency virus (HIV)-infected patients: A report of two cases [J] . Camila F Araújo, Iara B N Oliveira, Murilo B Silveira, 亚太热带医药杂志（英文版） . 2021,第006期

2. TUMOR　NECROSIS　FACTOR－ALPHA　SERUM　LEVELS　AND　IN　VITRO　PRODUCTION　IN　PATIENTS　WITH　HUMAN　IMMUNODEFICIENCY　VIRUS（HIV）　INFECTION [J] . 王一理, 司履生药物分析学报：英文版 . 1995,第001期

3. High Human Immunodeficiency Virus (HIV) Viral Load and Coinfection with Viral Hepatitis Are Associated with Liver Enzyme Abnormalities among HIV Seropositive Patients on Antiretroviral Therapy in the Lake Victoria Zone, Tanzania [J] . Shabani Iddi, Caroline A. Minja, Vitus Silago, AIDS Research and Treatment . 2019,第1期

4. Use of Sno Strip Filter-Paper Wicks for Collection of Genital-Tract Samples Allows Reproducible Determination of Human Immunodeficiency Virus Type 1 (HIV-1) RNA Viral Load with a Commercial HIV-1 Viral Load Assay [J] . Christopher H. Sherlock, Paula M. Lott, Deborah M. Money, Journal of Clinical Microbiology . 2006,第3期

5. Human Immunodeficiency Virus (HIV) 2 Superinfection in a Patient Receiving Antiretroviral Therapy With Longstanding HIV-1 Viral Load Suppression [J] . F Ceia, A Silva-Pinto, A C Carvalho, Open Forum Infectious Diseases . 2019,第4期

6. Simultaneous extraction of human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) RNA with the M1000 apparatus does not impair the measurement of the viral load of both viruses when tested by using the LCx PCR system [C] . T. Bourlet, S. Thamm, S. Pillet, European Congress of Virology . 2004

7. The role of the transmembrane and cytoplasmic domains of the VPU protein of human immunodeficiency virus type 1 (HIV-1) in the acute CD4+ T cell loss and disease in the simian human immunodeficiency virus (SHIV)/macaque model. [D] . Hout, David Richard. 2006

8. High Human Immunodeficiency Virus (HIV) Viral Load and Coinfection with Viral Hepatitis Are Associated with Liver Enzyme Abnormalities among HIV Seropositive Patients on Antiretroviral Therapy in the Lake Victoria Zone Tanzania [O] . Shabani Iddi, Caroline A. Minja, Vitus Silago, 2019

9. High Human Immunodeficiency Virus (HIV) Viral Load and Coinfection with Viral Hepatitis Are Associated with Liver Enzyme Abnormalities among HIV Seropositive Patients on Antiretroviral Therapy in the Lake Victoria Zone, Tanzania [O] . Shabani Iddi, Caroline A. Minja, Vitus Silago, 2019

1. Improvement in human immunodeficiency virus-1/acquired immune deficiency syndrome patients' well-being following administration of “Phyto V7” [J] . Ruben Wernik ,Jose L Priore ,Walter F Goldman . 世界临床传染病学杂志 . 2015,第2期

2. Prevalence of anal human papillomavirus infection in patients with human immunodeficiency virus infection:A systematic review [J] . Cinara Dourado Pereira Correia Santos ,Caio Caires Brandão ,Fernanda Santos Mota . 世界临床传染病学杂志 . 2021,第3期

3. Three amino acid residues in the envelope of human immunodeficiency virus type 1 CRF07_BC regulate viral neutralization susceptibility to the human monoclonal neutralizing antibody IgG1b12 [J] . Jianhui Nie ,Juan Zhao ,Qingqing Chen . 中国病毒学 . 2014,第005期

4. 人类免疫缺陷病毒(HIV)感染患者手术中的感染控制与防护 [C] . 张琼 . 中华护理学会第20届全国手术室护理学术交流会议 . 2016

5. Ⅰ型人类免疫缺陷病毒蛋白R（HIV-1Vpr）对胶质瘤作用的体外研究 [A] . 卢轶 . 2006